Who makes BI 764198 - Formula D?

BI 764198 - Formula D is developed by Boehringer Ingelheim.

What development phase is BI 764198 - Formula D in?

BI 764198 - Formula D is in Phase 1.

Last reviewed 2026-04-20 · How we verify

BI 764198 - Formula D

Boehringer Ingelheim · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	BI 764198 - Formula D
Sponsor	Boehringer Ingelheim
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BI 764198 - Formula D CI brief — competitive landscape report
BI 764198 - Formula D updates RSS · CI watch RSS
Boehringer Ingelheim portfolio CI